Can B Corp. (CANB)
OTCMKTS: CANB · Delayed Price · USD
0.0410
+0.0100 (32.26%)
May 2, 2024, 10:13 AM EDT - Market open
Can B Revenue
In the year 2023, Can B had annual revenue of $2.16M, a decrease of -67.76%. Revenue in the quarter ending December 31, 2023 was $376.89K, a -43.42% decrease year-over-year.
Revenue (ttm)
$2.16M
Revenue Growth
-67.76%
P/S Ratio
0.94
Revenue / Employee
$179,645
Employees
12
Market Cap
2.02M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.16M | -4.53M | -67.76% |
Dec 31, 2022 | 6.69M | 2.08M | 45.22% |
Dec 31, 2021 | 4.60M | 2.89M | 169.28% |
Dec 31, 2020 | 1.71M | -595.83K | -25.84% |
Dec 31, 2019 | 2.31M | 1.64M | 244.82% |
Dec 31, 2018 | 668.60K | 545.86K | 444.70% |
Dec 31, 2017 | 122.75K | 27.60K | 29.01% |
Dec 31, 2016 | 95.15K | -7.90K | -7.66% |
Dec 31, 2015 | 103.04K | 70.47K | 216.37% |
Dec 31, 2014 | 32.57K | 16.21K | 99.13% |
Dec 31, 2013 | 16.36K | -7.74K | -32.12% |
Dec 31, 2012 | 24.10K | 22.03K | 1,065.70% |
Dec 31, 2011 | 2.07K | -20.83K | -90.97% |
Dec 31, 2010 | 22.90K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
CANB News
- 7 weeks ago - Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million - GlobeNewsWire
- 7 months ago - Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado - GlobeNewsWire
- 10 months ago - Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising - GlobeNewsWire
- 1 year ago - Can B Corp. Reports Growth of 45% to Company All-Time High $6.7 Million Annual Revenue - GlobeNewsWire
- 1 year ago - Can B Corp. Completes Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange - GlobeNewsWire
- 1 year ago - Can B Corp. Reports Growth of 51% to $2.9 Million Revenue for Third Quarter 2022, the Highest Quarterly Revenue in Company History - GlobeNewsWire
- 1 year ago - Forever Brands Signs Manufacturing Agreement with Imbibe Wellness Solutions, LLC, a wholly owned subsidiary of Can B Corp for the Production of a new Plant Based Super Food Brand, Longevity by Brooke Burke Body TM. - PRNewsWire
- 1 year ago - Can B Corp. Inks Manufacturing & Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc. - GlobeNewsWire